OpenAI has launched ChatGPT Health, a secure platform for health consultations, developed with input from hundreds of doctors.
OpenAI has launched ChatGPT Health, a new platform designed specifically for health-related consultations, following significant user demand.
According to the company, over 230 million users engage the chatbot weekly for health inquiries, prompting this initiative, which was developed with insights from hundreds of medical professionals.
ChatGPT Health operates in a secure environment, ensuring that conversations are encrypted and kept separate from general dialogues, thereby protecting sensitive medical information.
The platform allows users to interact in a chat format while considering relevant health data. Users can pose questions such as "How is my cholesterol changing?" or request summaries of their test results, as well as upload files and images and utilize voice features.
Additionally, users can customize their experience by setting preferences for the types of inquiries they wish to prioritize or topics they want to avoid.
It is important to note that ChatGPT does not provide diagnoses or treatment recommendations. Instead, it assists users in interpreting health information, analyzing data from health tracking apps, and preparing for medical appointments.
To handle sensitive data like electronic medical records, OpenAI has partnered with the b.well platform, which adheres to HIPAA regulations. Users must give consent for data access, which they can revoke at any time.
The development of ChatGPT Health involved collaboration with over 260 doctors from 60 countries over a two-year period, ensuring that the tool meets clinical standards.
For quality assurance, OpenAI has implemented the HealthBench system to evaluate AI responses based on clinical safety, clarity, and the appropriateness of recommendations, rather than abstract accuracy.
Access to ChatGPT Health will be expanded to all users of the web and iOS platforms in the coming weeks, although it is currently undergoing testing with a limited group in the United States.
